Sandoz is currently the world's second-largest maker of biosimilars behind Pfizer (PFE.N), opens new tab. Saynor said dethroning the U.S. pharma giant ... new biosimilar product launches in ...

Basel, May 4, 2023 – Sandoz, a global leader in generic pharmaceuticals and biosimilars ... exclusive Sandoz rights to commercialize six products in the US across key therapeutic areas ...

Sandoz, a specialist in generic and biosimilar medicines ... over €100m in new manufacturing technology for the production of oral amoxicillin active pharmaceutical ingredient (API) at Kundl, Austria.

Sandoz announced the launch of its portfolio of OTC products in the Egyptian market at the beginning of 2022 Cairo – Sandoz Egypt Pharma and Ibnsina Pharma have announced a distribution and promotion ...

SteinCares serves as a bridge between pharmaceutical companies ... to market with many biosimilars and generic products, we were selected by Sandoz to do this transaction in Colombia,” he ...

Pharma companies involved in Vietnam are making more strategic moves to ease potential impacts in the face of US tariff ...

Products from Adalvo slated for near ... of healthcare systems worldwide Basel, May 4, 2023 - Sandoz, a global leader in generic pharmaceuticals and biosimilars, today announced that it has ...

Sandoz Egypt Pharma and Ibnsina Pharma have announced a distribution and promotion agreement for the Sandoz over-the-counter (OTC) portfolio of products. The step strengthens the company’s commitment ...